PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, Amsterdam, Netherlands. Electronic address: f.g.cobelens@amsterdamumc.nl.\', \'Department of Governance and Strategy, Developing Countries Vaccine Manufacturers\' Network International, Nyon, Switzerland.\', \'European & Developing Countries Clinical Trials Partnership, The Hague, Netherlands.\', \'Nextco, Oegstgeest, Netherlands.\', \'South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1473-3099(21)00810-010.1016/S1473-3099(21)00810-0
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 35240041
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Accelerating research and development of new vaccines against tuberculosis: a global roadmap.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35240041>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35240041>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all